Literature DB >> 31102109

Systematic Review and Meta-analysis of Pharmacist-Led Transitions of Care Services on the 30-Day All-Cause Readmission Rate of Patients with Congestive Heart Failure.

Connor McKay1, Chanhyun Park2, Jongwha Chang3, Marcia Brackbill1, Jae-Young Choi4, Jung Heon Lee4, Sean Hyungwoo Kim5.   

Abstract

BACKGROUND AND
OBJECTIVE: A systematic review and meta-analysis were performed to determine the cumulative effect of pharmacist-led transitions of care on the 30-day all-cause readmission rates of patients with congestive heart failure with the objective to isolate and assess the effect of pharmacy intervention to a condition-specific service. Previous studies that review pharmacist-led transitional care services involve multiple condition-specific services or a pharmacy service integrated into the healthcare team that presents complications in interpreting the independent effectiveness of component services by pharmacy professionals.
METHODS: A systematic review was conducted using articles identified from MEDLINE, CINAHL, Web of Science, Embase, the Cochrane Library, and clinicaltrials.gov databases for studies on congestive heart failure readmission rates based on transitions of care pharmacist services using detailed inclusion and exclusion criteria. Abstracts were screened for outcome of interest and appropriate transitions of care program structure. Practice and patient characteristics were described and compared to identify current practice trends. A meta-analysis was then performed utilizing previously identified studies from systematic analysis that reported the required data to calculate the effect size. Evidence was reviewed and appraised according to the Newcastle-Ottawa Scale for cohort studies.
RESULTS: The database search produced 443 potential articles for inclusion. Six articles were identified for inclusion in the systematic review based on abstract screening. Of the six articles included in the systematic review, three studies met inclusion criteria for a meta-analysis. Two studies in the meta-analysis stated a significant reduction in the 30-day all-cause readmission rate for patients with congestive heart failure, while the third depicted a reduction in readmission that was found to be non-significant. The pooled effect of the included articles found that pharmacist-led transitions of care services for patients with congestive heart failure had an increased odds to have lower all-cause readmission rates of patients with congestive heart failure (odds ratio = 2.19, 95% confidence interval 1.50-3.20). Based on the meta-analysis of three studies, pharmacist-led transitions of care services significantly reduced the odds of 30-day all-cause readmission rates in patients with congestive heart failure compared with standard-of-care discharge protocols.
CONCLUSION: Results of the meta-analysis demonstrate the capacity for pharmacist-led transitions of care programs to reduce 30-day all-cause readmission rates in patients with congestive heart failure compared with non-pharmacist discharge care. The financial implications of transitions of care pharmacist involvement have yet to be validated. In general, existing database search results highlight the lack of evidence detailing specific clinical outcomes of pharmacist-led transitions of care services in distinct chronic conditions. Future studies may serve to compare patient-centered outcomes between condition-specific services or across disciplines to provide the most cost-effective delivery of care.

Entities:  

Mesh:

Year:  2019        PMID: 31102109     DOI: 10.1007/s40261-019-00797-2

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  1 in total

1.  Impact of a pharmacy-based transitional care program on hospital readmissions.

Authors:  Weiyi Ni; Danielle Colayco; Jonathan Hashimoto; Kevin Komoto; Chandrakala Gowda; Bruce Wearda; Jeffrey McCombs
Journal:  Am J Manag Care       Date:  2017-03       Impact factor: 2.229

  1 in total
  10 in total

1.  Role and Contribution of the General Heart Failure Cardiologist: Further Expansion of the Multidisciplinary Heart Failure Approach.

Authors:  Melvin R Echols; Modele O Ogunniyi
Journal:  J Card Fail       Date:  2021-12-31       Impact factor: 6.592

2.  Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review.

Authors:  Erin Weeda; Rachael E Gilbert; Shelby J Kolo; Jason S Haney; Linh Tran Hazard; David J Taber; Robert Neal Axon
Journal:  J Pharm Pract       Date:  2021-12-28

3.  One Quarter of Medicare Hospitalizations in Patients with Systemic Lupus Erythematosus Readmitted within Thirty Days.

Authors:  Christie M Bartels; Ann Chodara; Yi Chen; Xing Wang; W Ryan Powell; Fangfang Shi; Maria Schletzbaum; Ann M Sheehy; Farah A Kaiksow; Andrea L Gilmore-Bykovskyi; Shivani Garg; Menggang Yu; Amy J Kind
Journal:  Semin Arthritis Rheum       Date:  2021-02-19       Impact factor: 5.431

4.  Factors associated with death in bedridden patients in China: A longitudinal study.

Authors:  Jing Cao; Tiantian Wang; Zhen Li; Ge Liu; Ying Liu; Chen Zhu; Jing Jiao; Jiaqian Li; Fangfang Li; Hongpeng Liu; Huaping Liu; Baoyun Song; Jingfen Jin; Yilan Liu; Xianxiu Wen; Shouzhen Cheng; Xia Wan; Xinjuan Wu
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

5.  From hospitalisation to primary care: integrative model of clinical pharmacy with patients implanted with a PICC line-research protocol for a prospective before-after study.

Authors:  Alix Marie Pouget; Elodie Civade; Philippe Cestac; Charlotte Rouzaud-Laborde
Journal:  BMJ Open       Date:  2021-04-07       Impact factor: 2.692

6.  An inpatient multidisciplinary educational approach to reduce 30-day heart failure readmissions.

Authors:  Ahmed Aljabri
Journal:  Saudi Pharm J       Date:  2021-03-25       Impact factor: 4.330

7.  The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial.

Authors:  Martin Schulz; Nina Griese-Mammen; Pia M Schumacher; Stefan D Anker; Friedrich Koehler; Christian Ruckes; Volker Rettig-Ewen; Rolf Wachter; Dietmar Trenk; Michael Böhm; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2020-07-23

8.  Rationale and Design of a Pharmacist-led Intervention for the Risk-Based Prevention of Heart Failure: The FIT-HF Pilot Study.

Authors:  Michael C Wang; Bridget Dolan; Benjamin H Freed; Lourdes Vega; Nikola Markoski; Amy E Wainright; Bonnie Kane; Laura E Seegmiller; Katharine Harrington; Alana A Lewis; Sanjiv J Shah; Clyde W Yancy; Ian J Neeland; Hongyan Ning; Donald M Lloyd-Jones; Sadiya S Khan
Journal:  Front Cardiovasc Med       Date:  2021-11-29

9.  A systematic review and meta-analysis of the effect of transitional care interventions on the prognosis of patients with heart failure.

Authors:  Xiuzhen Lin; Ruxiang Ji; Xia Wang; Ruomei Xin; Qiongyan Chen
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

10.  Development and validation of the Tool for Pharmacists to Predict 30-day hospital readmission in patients with Heart Failure (ToPP-HF).

Authors:  Melissa R Riester; Laura McAuliffe; Christine Collins; Andrew R Zullo
Journal:  Am J Health Syst Pharm       Date:  2021-09-07       Impact factor: 2.980

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.